IGHE and atopic eczema: In a similar study, intravenous injection of AD-MSCs resulted in a decreased number of degranulated mast cells, reduced IgE levels, and reduced concentrations of histamine, and prostaglandin E2 (PGE2) which resulted in the attenuation of atopic dermatitis clinical symptoms (42).